I-CERAM (EPA:ALICR) | Finanzwire

Basculer en Français

8301	Companies
115073	Keywords
55420	Articles
62512	Press releases

Home
Companies
I-CERAM

BRIEF

published on 11/07/2024 at 18:41, 13 days 23 hours ago

Pilot Study on Antibiotic-Loaded Ceramic Implant Launched

Innovation Clinical Study Cardiac Surgery Ceramic Implant Mediastinitis
REGULATED PRESS RELEASE

published on 11/07/2024 at 18:36, 13 days 23 hours ago

I.CERAM - Professor Pascal Leprince, Head of the Cardiac Surgery Department at the Pitié-Salpêtrière Hospital in Paris, has agreed to set up a pilot clinical
I.Ceram to conduct pilot clinical study on antibiotic-loaded Porous Ceramic Sternal Stabilisation Implant at Pitié-Salpêtrière Hospital in Paris with Professor Pascal Leprince. Implant aims to prevent bacterial contamination and stabilize chest walls

I.Ceram Clinical Study Antibiotic-loaded Implant Porous Ceramic Chest Wall Stabilization
BRIEF

published on 11/07/2024 at 18:15, 13 days 23 hours ago

Implementation of a clinical study at I.CERAM

Clinical Study Ceramic Implant Sternotomy Post-operative Infection Heart Surgery
BRIEF

published on 10/31/2024 at 20:31, 20 days 21 hours ago

Review of the First Half of 2024 for I.CERAM

Financial Results Turnover Restructuring Plan Judicial Recovery Extension Of Observation
BRIEF

published on 09/11/2024 at 17:58, 2 months 10 days ago

I.CERAM Combined General Meeting on September 26, 2024

Shareholders I.Ceram General Assembly Preparatory Documents Summons
BRIEF

published on 08/06/2024 at 19:50, 3 months 14 days ago

I.CERAM: Final 2023 accounts and publication of the Universal Registration Document

I.Ceram Universal Registration Document Legal Redress 2023 Accounts MDR Regulations
BRIEF

published on 06/25/2024 at 20:09, 4 months 25 days ago

I.CERAM - Extension to September 30, 2024 of the deadline for holding the General Meeting

I.Ceram Extension Annual Accounts General Assembly The Commercial Court
BRIEF

published on 06/06/2024 at 22:18, 5 months 14 days ago

I.CERAM 2023 annual results: a year marked by challenges

Financial Performance I.Ceram Orthopedic Implants 2023 Financial Results Legal Redress
BRIEF

published on 04/30/2024 at 18:05, 6 months 21 days ago

I.CERAM Postpones the Publication of its 2023 Results and the Universal Registration Document

I.Ceram 2023 Annual Results Universal Registration Document Legal Redress Postponement Of Publication
BRIEF

published on 04/24/2024 at 20:03, 6 months 26 days ago

I.Ceram in Judicial Reorganization to Safeguard its Future

I.Ceram Regulation Medical Innovation Legal Redress Bioceramic

Accesswire

Published on 11/21/2024 at 17:35, 39 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 44 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 44 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 2 hours 13 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 2 hours 14 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 17:58, 15 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 22 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 22 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 16:00, 2 hours 14 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 32 minutes ago

Edison issues report on Murray Income Trust (MUT)

Les Echos

Published on 11/21/2024 at 06:58, 11 hours 16 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 54 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE